共 45 条
- [31] Mature results from Hoosier Oncology Group GU04-75 phase II trial of cisplatin (C), gemcitabine (G), and bevacizumab (B) as first-line chemotherapy for metastatic urothelial carcinoma (UC)JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)Hahn, N. M.论文数: 0 引用数: 0 h-index: 0机构: Indiana Univ, Simon Canc Ctr, Indianapolis, IN 46204 USAStadler, W. M.论文数: 0 引用数: 0 h-index: 0机构: Indiana Univ, Simon Canc Ctr, Indianapolis, IN 46204 USAZon, R.论文数: 0 引用数: 0 h-index: 0机构: Indiana Univ, Simon Canc Ctr, Indianapolis, IN 46204 USAWaterhouse, D. M.论文数: 0 引用数: 0 h-index: 0机构: Indiana Univ, Simon Canc Ctr, Indianapolis, IN 46204 USAPicus, J.论文数: 0 引用数: 0 h-index: 0机构: Indiana Univ, Simon Canc Ctr, Indianapolis, IN 46204 USANattam, S. R.论文数: 0 引用数: 0 h-index: 0机构: Indiana Univ, Simon Canc Ctr, Indianapolis, IN 46204 USAJohnson, C. S.论文数: 0 引用数: 0 h-index: 0机构: Indiana Univ, Simon Canc Ctr, Indianapolis, IN 46204 USAPerkins, S. M.论文数: 0 引用数: 0 h-index: 0机构: Indiana Univ, Simon Canc Ctr, Indianapolis, IN 46204 USAWaddell, M. J.论文数: 0 引用数: 0 h-index: 0机构: Indiana Univ, Simon Canc Ctr, Indianapolis, IN 46204 USASweeney, C.论文数: 0 引用数: 0 h-index: 0机构: Indiana Univ, Simon Canc Ctr, Indianapolis, IN 46204 USA
- [32] Updated results from the multicenter phase II, ALTER-C001 trial: Efficacy and safety of anlotinib plus XELOX regimen as first-line treatment followed by maintenance monotherapy of anlotinib for patients with mCRCANNALS OF ONCOLOGY, 2022, 33 (07) : S720 - S721Jin, Y.论文数: 0 引用数: 0 h-index: 0机构: UESTC, Dept Gastrointestinal Surg, Affiliated Canc Hosp, Sch Med,Sichuan Canc Hosp & Inst, Chengdu, Peoples R China UESTC, Dept Med Oncol, Sichuan Canc Hosp & Inst, Affiliated Canc Hosp,Sch Med, Chengdu, Peoples R China UESTC, Dept Gastrointestinal Surg, Affiliated Canc Hosp, Sch Med,Sichuan Canc Hosp & Inst, Chengdu, Peoples R ChinaHan, Y.论文数: 0 引用数: 0 h-index: 0机构: Southwest Med Univ, Dept Med Oncol, Affiliated Hosp, Luzhou, Peoples R China UESTC, Dept Gastrointestinal Surg, Affiliated Canc Hosp, Sch Med,Sichuan Canc Hosp & Inst, Chengdu, Peoples R ChinaZhang, L.论文数: 0 引用数: 0 h-index: 0机构: Chongqing Univ, Dept Med Oncol, Three Gorges Hosp, Chongqing, Peoples R China UESTC, Dept Gastrointestinal Surg, Affiliated Canc Hosp, Sch Med,Sichuan Canc Hosp & Inst, Chengdu, Peoples R ChinaJin, Y.论文数: 0 引用数: 0 h-index: 0机构: UESTC, Dept Gastrointestinal Surg, Affiliated Canc Hosp, Sch Med,Sichuan Canc Hosp & Inst, Chengdu, Peoples R China UESTC, Dept Med Oncol, Sichuan Canc Hosp & Inst, Affiliated Canc Hosp,Sch Med, Chengdu, Peoples R China UESTC, Dept Gastrointestinal Surg, Affiliated Canc Hosp, Sch Med,Sichuan Canc Hosp & Inst, Chengdu, Peoples R ChinaSun, H.论文数: 0 引用数: 0 h-index: 0机构: Chongqing Univ, Dept Gastrointestinal Surg, Canc Hosp, Chongqing, Peoples R China UESTC, Dept Gastrointestinal Surg, Affiliated Canc Hosp, Sch Med,Sichuan Canc Hosp & Inst, Chengdu, Peoples R China
- [33] Blockade of HLA Antibody-Triggered Classical Complement Activation in Sera From Subjects Dosed With the Anti-C1s Monoclonal Antibody TNT009-Results from a Randomized First-in-Human Phase 1 TrialTRANSPLANTATION, 2017, 101 (10) : 2410 - 2418Muehlbacher, Jakob论文数: 0 引用数: 0 h-index: 0机构: Med Univ Vienna, Dept Surg, Vienna, Austria Med Univ Vienna, Dept Surg, Vienna, AustriaJilma, Bernd论文数: 0 引用数: 0 h-index: 0机构: Med Univ Vienna, Dept Clin Pharmacol, Wahringer Gurtel 18-20, A-1090 Vienna, Austria Med Univ Vienna, Dept Surg, Vienna, Austria论文数: 引用数: h-index:机构:Bartko, Johann论文数: 0 引用数: 0 h-index: 0机构: Med Univ Vienna, Dept Clin Pharmacol, Wahringer Gurtel 18-20, A-1090 Vienna, Austria Med Univ Vienna, Dept Surg, Vienna, AustriaEskandary, Farsad论文数: 0 引用数: 0 h-index: 0机构: Med Univ Vienna, Div Nephrol & Dialysis, Dept Med 3, Wahringer Gurtel 18-20, A-1090 Vienna, Austria Med Univ Vienna, Dept Surg, Vienna, AustriaSchoergenhofer, Christian论文数: 0 引用数: 0 h-index: 0机构: Med Univ Vienna, Dept Clin Pharmacol, Wahringer Gurtel 18-20, A-1090 Vienna, Austria Med Univ Vienna, Dept Surg, Vienna, AustriaSchwameis, Michael论文数: 0 引用数: 0 h-index: 0机构: Med Univ Vienna, Dept Clin Pharmacol, Wahringer Gurtel 18-20, A-1090 Vienna, Austria Med Univ Vienna, Dept Surg, Vienna, AustriaParry, Graham C.论文数: 0 引用数: 0 h-index: 0机构: True North Therapeut Inc, San Francisco, CA USA Med Univ Vienna, Dept Surg, Vienna, AustriaGilbert, James C.论文数: 0 引用数: 0 h-index: 0机构: True North Therapeut Inc, San Francisco, CA USA Med Univ Vienna, Dept Surg, Vienna, AustriaPanicker, Sandip论文数: 0 引用数: 0 h-index: 0机构: True North Therapeut Inc, San Francisco, CA USA Med Univ Vienna, Dept Surg, Vienna, AustriaBoehmig, Georg A.论文数: 0 引用数: 0 h-index: 0机构: Med Univ Vienna, Div Nephrol & Dialysis, Dept Med 3, Wahringer Gurtel 18-20, A-1090 Vienna, Austria Med Univ Vienna, Dept Surg, Vienna, Austria
- [34] Adding Mercaptopurine and Methotrexate to Alternate Week ATRA Maintenance Therapy Does Not Improve the Outcome for Adults with Acute Promyelocytic Leukemia (APL) in First Remission: Results From North American Leukemia Intergroup Trial C9710BLOOD, 2011, 118 (21) : 118 - 119Powell, Bayard L.论文数: 0 引用数: 0 h-index: 0机构: Wake Forest Univ, Ctr Comprehens Canc, Winston Salem, NC 27109 USA Wake Forest Univ, Ctr Comprehens Canc, Winston Salem, NC 27109 USAMoser, Barry K.论文数: 0 引用数: 0 h-index: 0机构: Duke Univ, CALGB Stat Ctr, Durham, NC USA Wake Forest Univ, Ctr Comprehens Canc, Winston Salem, NC 27109 USAStock, Wendy论文数: 0 引用数: 0 h-index: 0机构: Univ Chicago, Ctr Comprehens Canc, Chicago, IL 60637 USA Wake Forest Univ, Ctr Comprehens Canc, Winston Salem, NC 27109 USAGallagher, Robert E.论文数: 0 引用数: 0 h-index: 0机构: Albert Einstein Coll Med, Bronx, NY 10467 USA Wake Forest Univ, Ctr Comprehens Canc, Winston Salem, NC 27109 USAWillman, Cheryl L.论文数: 0 引用数: 0 h-index: 0机构: Univ New Mexico, Ctr Canc, Albuquerque, NM 87131 USA Wake Forest Univ, Ctr Comprehens Canc, Winston Salem, NC 27109 USAStone, Richard M.论文数: 0 引用数: 0 h-index: 0机构: Dana Farber Canc Inst, Boston, MA 02115 USA Wake Forest Univ, Ctr Comprehens Canc, Winston Salem, NC 27109 USARowe, Jacob M.论文数: 0 引用数: 0 h-index: 0机构: Technion Israel Inst Technol, Rambam Med Ctr, Haifa, Israel Wake Forest Univ, Ctr Comprehens Canc, Winston Salem, NC 27109 USACoutre, Steven E.论文数: 0 引用数: 0 h-index: 0机构: Stanford Univ, Sch Med, Div Hematol, Stanford, CA 94305 USA Stanford Univ, Sch Med, Div Oncol, Stanford, CA 94305 USA Stanford Univ, Sch Med, Stanford Canc Ctr, Stanford, CA 94305 USA Wake Forest Univ, Ctr Comprehens Canc, Winston Salem, NC 27109 USAFeusner, James H.论文数: 0 引用数: 0 h-index: 0机构: Childrens Hosp & Res Ctr, Oakland, CA USA Wake Forest Univ, Ctr Comprehens Canc, Winston Salem, NC 27109 USAGregory, John论文数: 0 引用数: 0 h-index: 0机构: Goryeb Childrens Hosp, Atlantic Hlth Syst, Morristown, NJ USA Wake Forest Univ, Ctr Comprehens Canc, Winston Salem, NC 27109 USACouban, Stephen论文数: 0 引用数: 0 h-index: 0机构: Dalhousie Univ, Halifax, NS, Canada Wake Forest Univ, Ctr Comprehens Canc, Winston Salem, NC 27109 USAAppelbaum, Frederick R.论文数: 0 引用数: 0 h-index: 0机构: Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA Wake Forest Univ, Ctr Comprehens Canc, Winston Salem, NC 27109 USATallman, Martin S.论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, Leukemia Serv, New York, NY 10021 USA Wake Forest Univ, Ctr Comprehens Canc, Winston Salem, NC 27109 USALarson, Richard A.论文数: 0 引用数: 0 h-index: 0机构: Univ Chicago, Ctr Comprehens Canc, Chicago, IL 60637 USA Wake Forest Univ, Ctr Comprehens Canc, Winston Salem, NC 27109 USA
- [35] VP10-2021: Cabozantinib (C) plus atezolizumab (A) versus sorafenib (S) as first-line systemic treatment for advanced hepatocellular carcinoma (aHCC): Results from the randomized phase III COSMIC-312 trialANNALS OF ONCOLOGY, 2022, 33 (01) : 114 - 116Kelley, R. K.论文数: 0 引用数: 0 h-index: 0机构: Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USAYau, T.论文数: 0 引用数: 0 h-index: 0机构: Univ Hong Kong, Dept Med, Queen Mary Hosp, Hong Kong, Peoples R China Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USACheng, A. -L.论文数: 0 引用数: 0 h-index: 0机构: NTUH Natl Taiwan Univ Hosp, Dept Oncol, Taipei, Taiwan Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USAKaseb, A.论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, GI Med Oncol Dept, Houston, TX USA Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USAQin, S.论文数: 0 引用数: 0 h-index: 0机构: Nanjing Chinese Med Univ, Canc Ctr Jinling Hosp, Nanjing, Peoples R China Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USAZhu, A. X.论文数: 0 引用数: 0 h-index: 0机构: Harvard Med Sch, Massachusetts Gen Hosp, Boston, MA 02115 USA Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USAChan, S.论文数: 0 引用数: 0 h-index: 0机构: Chinese Univ Hong Kong, Oncol, Hong Kong, Peoples R China Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USASukeepaisarnjaroen, W.论文数: 0 引用数: 0 h-index: 0机构: Khon Kaen Univ, Srinagarind Hosp, Dept Med, Khon Kaen, Thailand Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USABreder, V.论文数: 0 引用数: 0 h-index: 0机构: FSBSI N N Blokhin, Dept Clin Biotechnol, Russian Canc Res Ctr, Moscow, Russia Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USAVerset, G.论文数: 0 引用数: 0 h-index: 0机构: Univ Libre Bruxelles, Dept Gastroenterol Hepatopancreatol & Digest Onco, Erasme Univ Hosp, Brussels, Belgium Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USAGane, E.论文数: 0 引用数: 0 h-index: 0机构: Auckland City Hosp, New Zealand Liver Transplant Unit, Auckland, New Zealand Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USABorbath, I.论文数: 0 引用数: 0 h-index: 0机构: UCLouvain St Luc, Hepatogastroenterol, Clin Univ St Luc, Woluwe St Lambert, Belgium Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USARangel, J. D. Gomez论文数: 0 引用数: 0 h-index: 0机构: Clin Med Res, Med Oncol, Veracruz, Mexico Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USAMerle, P.论文数: 0 引用数: 0 h-index: 0机构: Hop Croix Rousse, Hepatol Unit, Lyon, France Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USABenzaghou, F. M.论文数: 0 引用数: 0 h-index: 0机构: Ipsen Biosci Inc, Global Oncol R&D Therapeut Area, Cambridge, MA USA Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USABanerjee, K.论文数: 0 引用数: 0 h-index: 0机构: Exelixis Inc, Dept Biostat, Alameda, CA USA Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USAHazra, S.论文数: 0 引用数: 0 h-index: 0机构: Exelixis, Clin Sci Clin Dev, Alameda, CA USA Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USAFawcett, J.论文数: 0 引用数: 0 h-index: 0机构: Exelixis Inc, Clin Dev, Alameda, CA USA Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USARimassa, L.论文数: 0 引用数: 0 h-index: 0机构: Humanitas Univ, Dept Biomed Sci, Pieve Emanuele, Italy Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA
- [36] Anlotinib plus chemotherapy as first-line therapy for gastrointestinal tumor patients with unresectable liver metastasis: Updated results from a multi-cohort, multicenter phase II trial ALTER-G-001-cohort CANNALS OF ONCOLOGY, 2023, 34 : S1533 - S1533Wu, J.论文数: 0 引用数: 0 h-index: 0机构: Shanghai Jiao Tong Univ, Ruijin Hosp, Dept Oncol, Sch Med, Shanghai, Peoples R China Shanghai Jiao Tong Univ, Ruijin Hosp, Dept Oncol, Sch Med, Shanghai, Peoples R ChinaZhou, C.论文数: 0 引用数: 0 h-index: 0机构: Shanghai Jiao Tong Univ, Ruijin Hosp, Dept Oncol, Sch Med, Shanghai, Peoples R China Shanghai Jiao Tong Univ, Ruijin Hosp, Dept Oncol, Sch Med, Shanghai, Peoples R ChinaYan, J.论文数: 0 引用数: 0 h-index: 0机构: Jiading Cent Hosp, Dept Oncol, Shanghai, Peoples R China Shanghai Jiao Tong Univ, Ruijin Hosp, Dept Oncol, Sch Med, Shanghai, Peoples R ChinaHan, Z.论文数: 0 引用数: 0 h-index: 0机构: Xuzhou Med Univ, Affiliated Hosp, Dept Oncol, Xuzhou, Jiangsu, Peoples R China Shanghai Jiao Tong Univ, Ruijin Hosp, Dept Oncol, Sch Med, Shanghai, Peoples R ChinaWang, C.论文数: 0 引用数: 0 h-index: 0机构: Jiading Cent Hosp, Dept Oncol, Shanghai, Peoples R China 3 Peoples Hosp Yancheng, Dept Oncol, Yancheng, Peoples R China Shanghai Jiao Tong Univ, Ruijin Hosp, Dept Oncol, Sch Med, Shanghai, Peoples R ChinaQin, Z.论文数: 0 引用数: 0 h-index: 0机构: Zhejiang Prov Peoples Hosp, Dept Oncol, Hangzhou, Peoples R China Shanghai Jiao Tong Univ, Ruijin Hosp, Dept Oncol, Sch Med, Shanghai, Peoples R ChinaJiang, J.论文数: 0 引用数: 0 h-index: 0机构: Shanghai Jiao Tong Univ, Ruijin Hosp, Dept Oncol, Sch Med, Shanghai, Peoples R China Shanghai Jiao Tong Univ, Ruijin Hosp, Dept Oncol, Sch Med, Shanghai, Peoples R ChinaWang, C.论文数: 0 引用数: 0 h-index: 0机构: Jiading Cent Hosp, Dept Oncol, Shanghai, Peoples R China 3 Peoples Hosp Yancheng, Dept Oncol, Yancheng, Peoples R China Shanghai Jiao Tong Univ, Ruijin Hosp, Dept Oncol, Sch Med, Shanghai, Peoples R ChinaTang, X.论文数: 0 引用数: 0 h-index: 0机构: Ruijin Hosp, Wuxi Branch, Dept Oncol, Wuxi, Jiangsu, Peoples R China Shanghai Jiao Tong Univ, Ruijin Hosp, Dept Oncol, Sch Med, Shanghai, Peoples R ChinaZhu, L.论文数: 0 引用数: 0 h-index: 0机构: Nanjing Med Univ, Affiliated Hosp 1, Jiangsu Prov Hosp, Dept Oncol, Nanjing, Peoples R China Shanghai Jiao Tong Univ, Ruijin Hosp, Dept Oncol, Sch Med, Shanghai, Peoples R ChinaChen, J.论文数: 0 引用数: 0 h-index: 0机构: Ningbo Univ, Affiliated Peoples Hosp, Dept Oncol, Ningbo, Peoples R China Shanghai Jiao Tong Univ, Ruijin Hosp, Dept Oncol, Sch Med, Shanghai, Peoples R ChinaMao, Y.论文数: 0 引用数: 0 h-index: 0机构: Jiangnan Univ, Wuxi Peoples Hosp 4, Dept Oncol, Wuxi, Jiangsu, Peoples R China Shanghai Jiao Tong Univ, Ruijin Hosp, Dept Oncol, Sch Med, Shanghai, Peoples R ChinaWei, X.论文数: 0 引用数: 0 h-index: 0机构: Nanjing First Hosp, Dept Oncol, Nanjing, Peoples R China Shanghai Jiao Tong Univ, Ruijin Hosp, Dept Oncol, Sch Med, Shanghai, Peoples R ChinaShangguan, C.论文数: 0 引用数: 0 h-index: 0机构: Shanghai Jiao Tong Univ, Ruijin Hosp, Dept Oncol, Sch Med, Shanghai, Peoples R China Shanghai Jiao Tong Univ, Ruijin Hosp, Dept Oncol, Sch Med, Shanghai, Peoples R ChinaZhang, J.论文数: 0 引用数: 0 h-index: 0机构: Shanghai Jiao Tong Univ, Ruijin Hosp, Dept Oncol, Sch Med, Shanghai, Peoples R China Shanghai Jiao Tong Univ, Ruijin Hosp, Dept Oncol, Sch Med, Shanghai, Peoples R China
- [37] Anlotinib plus chemotherapy as first-line therapy for patients with gastrointestinal tumor with unresectable liver metastasis: Updated results from a multi-cohort, multi-center phase II trial, ALTER-G-001-cohort CJOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)Wu, Junwei论文数: 0 引用数: 0 h-index: 0机构: Shanghai Jiao Tong Univ, Ruijin Hosp, Sch Med, Dept Oncol, Shanghai, Peoples R ChinaZhou, Chenfei论文数: 0 引用数: 0 h-index: 0机构: Shanghai Jiao Tong Univ, Ruijin Hosp, Sch Med, Dept Oncol, Shanghai, Peoples R ChinaYan, Jun论文数: 0 引用数: 0 h-index: 0机构: Shanghai Jiao Tong Univ, Ruijin Hosp, Sch Med, Dept Oncol, Shanghai, Peoples R ChinaHan, Zhengxiang论文数: 0 引用数: 0 h-index: 0机构: Shanghai Jiao Tong Univ, Ruijin Hosp, Sch Med, Dept Oncol, Shanghai, Peoples R ChinaWang, Chun论文数: 0 引用数: 0 h-index: 0机构: Shanghai Jiao Tong Univ, Ruijin Hosp, Sch Med, Dept Oncol, Shanghai, Peoples R ChinaQin, Zhiquan论文数: 0 引用数: 0 h-index: 0机构: Shanghai Jiao Tong Univ, Ruijin Hosp, Sch Med, Dept Oncol, Shanghai, Peoples R ChinaJiang, Jinling论文数: 0 引用数: 0 h-index: 0机构: Shanghai Jiao Tong Univ, Ruijin Hosp, Sch Med, Dept Oncol, Shanghai, Peoples R ChinaWang, Chunbing论文数: 0 引用数: 0 h-index: 0机构: Shanghai Jiao Tong Univ, Ruijin Hosp, Sch Med, Dept Oncol, Shanghai, Peoples R ChinaTang, Xinyu论文数: 0 引用数: 0 h-index: 0机构: Shanghai Jiao Tong Univ, Ruijin Hosp, Sch Med, Dept Oncol, Shanghai, Peoples R ChinaZhu, Lingjun论文数: 0 引用数: 0 h-index: 0机构: Shanghai Jiao Tong Univ, Ruijin Hosp, Sch Med, Dept Oncol, Shanghai, Peoples R ChinaChen, Jun论文数: 0 引用数: 0 h-index: 0机构: Shanghai Jiao Tong Univ, Ruijin Hosp, Sch Med, Dept Oncol, Shanghai, Peoples R ChinaMao, Yong论文数: 0 引用数: 0 h-index: 0机构: Shanghai Jiao Tong Univ, Ruijin Hosp, Sch Med, Dept Oncol, Shanghai, Peoples R ChinaZhu, Liangjun论文数: 0 引用数: 0 h-index: 0机构: Shanghai Jiao Tong Univ, Ruijin Hosp, Sch Med, Dept Oncol, Shanghai, Peoples R ChinaWei, Xiaowei论文数: 0 引用数: 0 h-index: 0机构: Shanghai Jiao Tong Univ, Ruijin Hosp, Sch Med, Dept Oncol, Shanghai, Peoples R ChinaShangguan, Chengfang论文数: 0 引用数: 0 h-index: 0机构: Shanghai Jiao Tong Univ, Ruijin Hosp, Sch Med, Dept Oncol, Shanghai, Peoples R ChinaZhang, Jun论文数: 0 引用数: 0 h-index: 0机构: Shanghai Jiao Tong Univ, Ruijin Hosp, Sch Med, Dept Oncol, Shanghai, Peoples R China
- [38] Anlotinib plus chemotherapy as first-line therapy for gastrointestinal tumor patients with unresectable liver metastasis: Updated results from a multi-cohort, multi-center phase II trial ALTER-G-001-cohort CCANCER RESEARCH, 2024, 84 (07)Wu, Junwei论文数: 0 引用数: 0 h-index: 0Zhou, Chenfei论文数: 0 引用数: 0 h-index: 0Yan, Jun论文数: 0 引用数: 0 h-index: 0Han, Zhengxiang论文数: 0 引用数: 0 h-index: 0Wang, Chun论文数: 0 引用数: 0 h-index: 0Qin, Zhiquan论文数: 0 引用数: 0 h-index: 0Jiang, Jinling论文数: 0 引用数: 0 h-index: 0Wang, Chunbin论文数: 0 引用数: 0 h-index: 0Tang, Xinyu论文数: 0 引用数: 0 h-index: 0Zhu, Lingjun论文数: 0 引用数: 0 h-index: 0Chen, Jun论文数: 0 引用数: 0 h-index: 0Mao, Yong论文数: 0 引用数: 0 h-index: 0Wei, Xiaowei论文数: 0 引用数: 0 h-index: 0Shangguan, Chengfang论文数: 0 引用数: 0 h-index: 0Zhang, Jun论文数: 0 引用数: 0 h-index: 0
- [39] BEAT-meso: A randomized phase III study of bevacizumab (B) and standard chemotherapy (C) with or without atezolizumab (A), as first-line treatment (TX) for advanced pleural mesothelioma (PM)-Results from the ETOP 13-18 trial.JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (17_SUPPL) : LBA8002 - LBA8002Popat, Sanjay论文数: 0 引用数: 0 h-index: 0机构: Royal Marsden Hosp NHS Fdn Trust, London, England Royal Marsden Hosp NHS Fdn Trust, London, EnglandFelip, Enriqueta论文数: 0 引用数: 0 h-index: 0机构: Vall dHebron Univ Hosp, Vall dHebron Inst Oncol VHIO, Med Oncol Serv, Barcelona, Spain Royal Marsden Hosp NHS Fdn Trust, London, EnglandDafni, Urania论文数: 0 引用数: 0 h-index: 0机构: Natl & Kapodistrian Univ Athens, Athens, Greece Frontier Sci Fdn Hellas, Athens, Greece Royal Marsden Hosp NHS Fdn Trust, London, EnglandPope, Anthony论文数: 0 引用数: 0 h-index: 0机构: Clatterbridge Canc Ctr, Liverpool, England Royal Marsden Hosp NHS Fdn Trust, London, EnglandPerez, Susana Cedres论文数: 0 引用数: 0 h-index: 0机构: Vall dHebron Univ Hosp, Vall dHebron Inst Oncol VHIO, Barcelona, Spain Royal Marsden Hosp NHS Fdn Trust, London, EnglandShah, Riyaz N. H.论文数: 0 引用数: 0 h-index: 0机构: Maidstone & Tunbridge Wells NHS Trust, Kent, England Royal Marsden Hosp NHS Fdn Trust, London, Englandde Marinis, Filippo论文数: 0 引用数: 0 h-index: 0机构: European Inst Oncol, Milan, Italy Royal Marsden Hosp NHS Fdn Trust, London, EnglandSmith, Laura Cove论文数: 0 引用数: 0 h-index: 0机构: Univ Manchester, Christie NHS Fdn Trust, Manchester, England Royal Marsden Hosp NHS Fdn Trust, London, EnglandCaro, Reyes Bernabe论文数: 0 引用数: 0 h-index: 0机构: Hosp Univ Virgen del Rocio, Seville, Spain Royal Marsden Hosp NHS Fdn Trust, London, EnglandFrueh, Martin论文数: 0 引用数: 0 h-index: 0机构: Kantonsspital St Gallen, St Gallen, Switzerland Royal Marsden Hosp NHS Fdn Trust, London, EnglandNackaerts, Kristiaan论文数: 0 引用数: 0 h-index: 0机构: Katholieke Univ Leuven, Univ Hosp Leuven, Leuven, Belgium Royal Marsden Hosp NHS Fdn Trust, London, EnglandGreillier, Laurent论文数: 0 引用数: 0 h-index: 0机构: Aix Marseille Univ AMU, Assistance Publ Hop Marseille AP HM, Marseille, France Royal Marsden Hosp NHS Fdn Trust, London, EnglandScherz, Amina论文数: 0 引用数: 0 h-index: 0机构: Univ Bern, Bern Univ Hosp, Dept Med Oncol, Inselspital, Bern, Switzerland Royal Marsden Hosp NHS Fdn Trust, London, England论文数: 引用数: h-index:机构:Schaer, Saemi论文数: 0 引用数: 0 h-index: 0机构: Swiss Grp Clin Canc Res SAKK, Bern, Switzerland Royal Marsden Hosp NHS Fdn Trust, London, EnglandPrince, Spasenija Savic论文数: 0 引用数: 0 h-index: 0机构: Univ Basel, Univ Hosp Basel, Inst Med Genet & Pathol, Basel, Switzerland Royal Marsden Hosp NHS Fdn Trust, London, EnglandRoschitzki-Voser, Heidi论文数: 0 引用数: 0 h-index: 0机构: ETOP IBCSG Partners Fdn, Bern, Switzerland Royal Marsden Hosp NHS Fdn Trust, London, EnglandRuepp, Barbara论文数: 0 引用数: 0 h-index: 0机构: ETOP IBCSG Partners Fdn, Bern, Switzerland Royal Marsden Hosp NHS Fdn Trust, London, EnglandPeters, Solange论文数: 0 引用数: 0 h-index: 0机构: Ctr Hosp Univ Vaudois CHUV, Lausanne Univ Hosp, Lausanne, Switzerland Royal Marsden Hosp NHS Fdn Trust, London, EnglandStahel, Rolf A.论文数: 0 引用数: 0 h-index: 0机构: ETOP IBCSG Partners Fdn, Bern, Switzerland Royal Marsden Hosp NHS Fdn Trust, London, England
- [40] Pevonedistat (MLN4924), an Investigational, First-in-Class NAE Inhibitor, in Combination with Azacitidine in Elderly Patients with Acute Myeloid Leukemia (AML) Considered Unfit for Conventional Chemotherapy: Updated Results from the Phase 1 C15009 TrialBLOOD, 2014, 124 (21)Swords, Ronan T.论文数: 0 引用数: 0 h-index: 0机构: Univ Miami Hosp, Sylvester Comprehens Canc Ctr, Miami, FL USA Univ Miami Hosp, Sylvester Comprehens Canc Ctr, Miami, FL USASavona, Michael R.论文数: 0 引用数: 0 h-index: 0机构: Vanderbilt Univ, Med Ctr, Nashville, TN USA Univ Miami Hosp, Sylvester Comprehens Canc Ctr, Miami, FL USAMaris, Michael B.论文数: 0 引用数: 0 h-index: 0机构: Colorado Blood Canc Inst, Denver, CO USA Univ Miami Hosp, Sylvester Comprehens Canc Ctr, Miami, FL USAErba, Harry P.论文数: 0 引用数: 0 h-index: 0机构: Univ Alabama Birmingham, Birmingham, AL USA Univ Miami Hosp, Sylvester Comprehens Canc Ctr, Miami, FL USABerdeja, Jesus G.论文数: 0 引用数: 0 h-index: 0机构: Sarah Cannon Res Inst, Nashville, TN USA Univ Miami Hosp, Sylvester Comprehens Canc Ctr, Miami, FL USAForan, James M.论文数: 0 引用数: 0 h-index: 0机构: Mayo Clin, Jacksonville, FL 32224 USA Univ Miami Hosp, Sylvester Comprehens Canc Ctr, Miami, FL USAHua, Zhaowei论文数: 0 引用数: 0 h-index: 0机构: Takeda Pharmaceut Int Co, Cambridge, MA USA Univ Miami Hosp, Sylvester Comprehens Canc Ctr, Miami, FL USAFaessel, Helene M.论文数: 0 引用数: 0 h-index: 0机构: Takeda Pharmaceut Int Co, Cambridge, MA USA Univ Miami Hosp, Sylvester Comprehens Canc Ctr, Miami, FL USADash, Ajeeta B.论文数: 0 引用数: 0 h-index: 0机构: Takeda Pharmaceut Int Co, Cambridge, MA USA Univ Miami Hosp, Sylvester Comprehens Canc Ctr, Miami, FL USASedarati, Farhad论文数: 0 引用数: 0 h-index: 0机构: Takeda Pharmaceut Int Co, Cambridge, MA USA Univ Miami Hosp, Sylvester Comprehens Canc Ctr, Miami, FL USADezube, Bruce J.论文数: 0 引用数: 0 h-index: 0机构: Takeda Pharmaceut Int Co, Cambridge, MA USA Univ Miami Hosp, Sylvester Comprehens Canc Ctr, Miami, FL USAMedeiros, Bruno C.论文数: 0 引用数: 0 h-index: 0机构: Stanford Univ, Stanford, MA USA Univ Miami Hosp, Sylvester Comprehens Canc Ctr, Miami, FL USA